secwatch / observer

Debt Financings

New loans, notes, and credit facilities disclosed under 8-K Items 2.03/2.04.

8-K items 2.03, 2.04 JSON
CTRA Coterra Energy Inc.

Coterra Energy Inc. incurred senior notes of $500,000,000 aggregate principal amount at 5.60% maturing March 15, 2034.

“Coterra Energy Inc. (the “Company”) closed its previously announced registered public offering of $500,000,000 aggregate principal amount of its 5.60% senior notes due 2034 (the “Notes”) on March 13, 2024. The Notes will mature on March 15, 2034.”
HUM HUMANA INC

HUMANA INC incurred senior notes of $1,250 million aggregate principal amount of its 5.375% Senior Notes due 2031 and $1,000 million aggregate principal amo with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC at 5.375% and 5.750% maturing April 15, 2031 and April 15, 2054.

“On March 13, 2024, the Company completed a public offering of the 2031 Senior Notes and the 2054 Senior Notes.”
IGTA Inception Growth Acquisition Ltd

Inception Growth Acquisition Ltd incurred loan of $400,000 with Soul Venture Partners LLC at does not bear interest maturing upon the closing of a business combination by the Company.

“On March 12, 2024, Inception Growth Acquisition Limited (the “Company”) issued an unsecured promissory note in the aggregate principal amount of $400,000 (the “Note”) to Soul Venture Partners LLC, the Company’s initial public offering sponsor (“Sponsor”). The Note does not bear interest and matures upon the closing of a business combination by the Company.”
OSRH OSR Holdings, Inc.

OSR Holdings, Inc. incurred loan of $60,000 with Josh Pan at not interest bearing maturing earlier of: (i) August 8, 2024 or (ii) the date on which the Company consummates an initial business combination.

“On March 8, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $60,000 to Josh Pan”
Enviva Inc.

Enviva Inc. faced acceleration on debt with Mississippi Business Finance Corporation.

“The filing of the Bankruptcy Petitions described above constitutes an event of default and acceleration under each of the following debt instruments”
Enviva Inc.

Enviva Inc. faced acceleration on loan with The Industrial Development Authority of Sumter County.

“The filing of the Bankruptcy Petitions described above constitutes an event of default and acceleration under each of the following debt instruments”
Enviva Inc.

Enviva Inc. faced acceleration on debt with Wilmington Trust, N.A., as trustee.

“The filing of the Bankruptcy Petitions described above constitutes an event of default and acceleration under each of the following debt instruments”
Enviva Inc.

Enviva Inc. faced acceleration on credit facility with Ankura Trust Company, LLC, as Administrative Agent and as Collateral Agent.

“The filing of the Bankruptcy Petitions described above constitutes an event of default and acceleration under each of the following debt instruments”
Enviva Inc.

Enviva Inc. faced acceleration on senior notes with Wilmington Savings Fund Society, FSB (as successor to Wilmington Trust, N.A.), as trustee.

“The filing of the Bankruptcy Petitions described above constitutes an event of default and acceleration under each of the following debt instruments”
DKL Delek Logistics Partners, LP

Delek Logistics Partners, LP incurred senior notes of $650,000,000 at 8.625% maturing March 15, 2029.

“the Issuers issued $650,000,000 in aggregate principal amount of 8.625% senior notes due 2029”
ESRT Empire State Realty Trust, Inc.

Empire State Realty Trust, Inc. incurred term loan of $95 million with Bank of America, N.A. (as administrative agent) at 1.500% to 2.050% per annum, in the case of term loans maturing March 8, 2027.

“the other parties named therein. The BofA Credit Agreement is comprised of a $620 million senior unsecured revolving credit facility (the “ Revolving Credit Facility ”) and a $95 million term loan facility (the “ BofA Term Loan Facility ”, and, together with the Revolving Credit Facility, the “ BofA Facilities ”). The Operating Partnership may request that the”
ESRT Empire State Realty Trust, Inc.

Empire State Realty Trust, Inc. incurred revolving credit of $620 million with Bank of America, N.A. (as administrative agent) at the term SOFR rate, plus, a margin ranging from (x) 1.300% to 1.700% per annum, maturing March 8, 2028.

“among the Operating Partnership, the Company, Bank of America, N.A., as administrative agent, and the other parties named therein. The BofA Credit Agreement is comprised of a $620 million senior unsecured revolving credit facility (the “ Revolving Credit Facility ”) and a $95 million term loan facility (the “ BofA Term Loan Facility ”, and, together with the”
GMBL ESPORTS ENTERTAINMENT GROUP, INC.

ESPORTS ENTERTAINMENT GROUP, INC. incurred loan of $1.42 million at 10% per annum maturing March 7, 2026.

“the Company issued the Holder a secured promissory note (the “Secured Note”), for approximately $1.42 million in cash and certain amendments to the terms of the Series C Preferred Stock and Series D Preferred Stock. The key terms of the Secured Note Agreement include: ● Security of the Secured Note balance by a first priority security interest in all of the Company’s tangible and intangible personal property; ● Accrued interest to the outstanding principal balance of the Secured Note at a rate of 10% per annum. All interest shall be quarterly in-kind by adding the amount of accrued interest to the outstanding principal balance of the Secured Note on the last Business Day of each calendar quarter; ● Maturity date of March 7, 2026;”
GPUS Hyperscale Data, Inc.

Hyperscale Data, Inc. incurred convertible notes of an aggregate of $2,000,000 principal face amount convertible promissory notes with two institutional investors at accrue interest at the rate of 6% per annum, unless an event of default (as defi maturing mature on June 12, 2024, provided, however, that the Company shall have the right, upon written notice to the Investors, to extend the maturity date to Septembe.

“On March 11, 2024 (the “ Effective Date ”), Ault Alliance, Inc. (the “ Company ”) entered into a note purchase agreement (the “ Purchase Agreement ”) with two institutional investors (the “ Investors ”) pursuant to which the Investors agreed, severally and not jointly, to acquire, and the Company agreed to issue and sell in a registered direct offering to the Investors (the “ Offering ”), an aggregate of $2,000,000 principal face amount convertible promissory notes (the “ Notes ”), subject to customary closing conditions.”
Real Good Food Company, Inc.

Real Good Food Company, Inc. amended credit facility of $45.0 million second lien loan agreement with PMC Financial Services Group, LLC at applicable interest maturing December 31, 2025.

“(“PMC”), dated June 30, 2016 (the “Existing Credit Facility”). The Amendment amended the Existing Credit Facility to allow for the following: • Increased the principal amount of $45.0 million second lien loan agreement with PMC maturing on December 31, 2025, by an additional $45.0 million. All other original terms of the second lien loan as described in the Company’s”
CLDI Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. amended convertible notes of $1.5 million with an investor at 10.0% per annum maturing March 8, 2028.

“On March 11, 2024, the Company entered into an amendment to the $1.5 million convertible note (the "Note Amendment"), which amended Section 1(c) pertaining to conditions to closing, by deleting Section 1(c)(iii) in its entirety, which previously provided that the Principal Amount be wired to the Company’s bank account.”
CLDI Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. incurred convertible notes of $1.5 million with an investor at 10.0% per annum maturing March 8, 2028.

“the Company issued to the investor a $1.5 million convertible note in consideration for the settlement of all claims related to the Supplemental Funding Agreements”
CLDI Calidi Biotherapeutics, Inc.

Calidi Biotherapeutics, Inc. incurred convertible notes of $2.0 million with an investor at 10.0% per annum maturing March 8, 2028.

“the investor purchased a $2.0 million convertible note from the Company for cash”
Li-Cycle Holdings Corp.

Li-Cycle Holdings Corp. incurred convertible notes of $75,000,000 with Glencore Ltd. and Glencore Canada Corporation at secured overnight financing rate plus five percent (5%) per annum if interest is maturing fifth anniversary of the closing.

“On March 11, 2024, Li-Cycle Holdings Corp. (the “ Company ”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”) with Glencore Ltd. (“ Glencore Intermediate ”), and Glencore Canada Corporation (“ Glencore ”, and together with Glencore Intermediate, the “ Glencore Parties ”), pursuant to which the Company agreed to issue and sell to Glencore a senior secured convertible note (the “ Senior Secured Convertible Note ”) in an aggregate principal amount of $75,000,000”
Airspan Networks Holdings Inc.

Airspan Networks Holdings Inc. amended convertible notes with the purchasers party thereto and the administrative and collateral agent.

“In connection with the Sixth A&R Credit Agreement, the Company modified the terms of its Senior Secured Convertible Note Purchase and Guarantee Agreement, dated July 30, 2021 (as further amended, amended and restated, restated, supplemented or otherwise modified from time to time prior to the Effective Date, the "Note Purchase Agreement") pursuant to the Limited Waiver and Consent, Seventh Amendment to Senior Secured Convertible Note Purchase and Guarantee Agreement and Reaffirmation of Note Documents, dated the Effective Date (the "NPA Amendment"), among the Company, ANI, certain of its subsidiaries as guarantors, the purchasers party thereto and the administrative and collateral agent.”
Airspan Networks Holdings Inc.

Airspan Networks Holdings Inc. incurred term loan of $18 million with DBFIP ANI LLC, as administrative agent and collateral agent at Base Rate (as defined in the Sixth A&R Credit Agreement) or the Adjusted Term SO maturing December 30, 2024.

“The Sixth A&R Credit Agreement establishes a new delayed draw term loan commitment of an aggregate amount of $18 million, to be drawn in two tranches of $8 million and $10 million (the "Sixth Restatement Delayed Draw Term Loans"), which will accrue interest at a variable rate per annum equal to either the Base Rate (as defined in the Sixth A&R Credit Agreement) or the Adjusted Term SOFR (as defined in the Sixth A&R Credit Agreement), plus between 9.00% and 14.00% per annum, which shall be calculated based on the applicable Net EBITDA Leverage Ratio (as defined in the Sixth A&R Credit Agreement).”
Astra Space, Inc.

Astra Space, Inc. incurred senior notes of $200,000 in aggregate original principal amount with Ulrich Gall at 12.0% maturing 2025.

“On March 8, 2024, the Company closed a subsequent financing (together with the March 6 Financing and the March 7 Financing, the “ Subsequent Financings ”) with Ulrich Gall (together with Astera and ERAS, the “ Additional Investors ), pursuant to the Purchase Agreement, in which Mr. Gall purchased $200,000 in aggregate original principal amount of a 12.0% Senior Secured Convertible Note due 2025”
Astra Space, Inc.

Astra Space, Inc. incurred senior notes of $1,000,000 in aggregate original principal amount with ERAS Capital, LLC at 12.0% maturing 2025.

“On March 7, 2024, following the signing of the Merger Agreement and the Limited Consent, the Company closed a subsequent financing (the “ March 7 Financing ”) with ERAS Capital, LLC (“ ERAS ”), pursuant to the Purchase Agreement, in which ERAS purchased (i) $1,000,000 in aggregate original principal amount of a 12.0% Senior Secured Convertible Note due 2025”
Astra Space, Inc.

Astra Space, Inc. incurred senior notes of $5,000,000 in aggregate original principal amount with Astera at 12.0% maturing 2025.

“On March 6, 2024, the Company closed a subsequent financing (the “ March 6 Financing ”) with Astera, pursuant to the Purchase Agreement, in which Astera purchased (i) $5,000,000 in aggregate original principal amount of a 12.0% Senior Secured Convertible Notes due 2025”
AIOT Powerfleet, Inc.

Powerfleet, Inc. incurred term loan of $85 million with FirstRand Bank Limited (acting through its Rand Merchant Bank division) maturing three years following the closing date.

“RMB has agreed to provide the Company with two term loan facilities in an aggregate principal amount of $85 million”
PLRX PLIANT THERAPEUTICS, INC.

PLIANT THERAPEUTICS, INC. incurred credit facility of $150.0 million with Oxford Finance LLC at (i) the greater of (a) 1-month term SOFR and (b) three and one-half percent (3.5 maturing March 1, 2029, which may be extended to March 1, 2030.

“pursuant to which, the Lenders have agreed to lend the Company, subject to the terms and conditions therein, a series of term loans up to an aggregate principal amount of $150.0 million (the “Term Loans”), of which $50.0 million is subject to the Lender’s sole discretion. Pursuant to the Agreement, the Company drew an initial Term Loan of $30.0 million on the”
CPB CAMPBELL'S Co

CAMPBELL'S Co incurred term loan of $2 billion with Bank of America, N.A., as administrative agent maturing October 8, 2024.

“on the date hereof, the Company borrowed an aggregate principal amount of $2 billion under the Credit Agreement”
BLACKSTAR ENTERPRISE GROUP, INC.

BLACKSTAR ENTERPRISE GROUP, INC. reported a default on convertible notes of remaining principal balance of $33,682 with GS Capital Partners LLC at roughly 170% interest rate.

“of shares to convert against the remaining principal and interest on a Promissory Note entered into on October 11, 2021, which had a remaining principal balance of $33,682. At the outset of the case, a temporary restraining order was entered preventing the Company from trading any shares. As currently postured, Plaintiff seeks specific performance”
Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P. incurred senior notes of $200.0 million aggregate principal amount with Wilmington Trust, National Association at 9.25% maturing July 15, 2029.

“On March 7, 2024, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”) issued $200.0 million aggregate principal amount of a new series of the Issuers’ 9.25% Senior Secured First Lien Notes due 2029 (the “Notes”)”
Lazard Group LLC

Lazard Group LLC incurred senior notes of $400,000,000 with The Bank of New York Mellon at 6.000% per year maturing March 15, 2031.

“On March 12, 2024, Lazard Group LLC (the “Company”), a subsidiary of Lazard, Inc., completed its previously announced offering of an aggregate principal amount of $400,000,000 of the Company’s 6.000% Senior Notes due 2031”
LAZ Lazard, Inc.

Lazard, Inc. incurred senior notes of $400,000,000 with Citigroup Global Markets Inc. (representative of several underwriters) at 6.000% per year maturing March 15, 2031.

“On March 12, 2024, Lazard Group LLC (“Lazard Group”), a subsidiary of Lazard, Inc., completed its previously announced offering of an aggregate principal amount of $400,000,000 of Lazard Group’s 6.000% Senior Notes due 2031 (the “Notes”) in a registered public offering pursuant to Lazard Group’s shelf registration statement on Form S-3 (Registration No. 333-263578).”
XEROX CORP

XEROX CORP incurred convertible notes of $350 million aggregate principal amount with initial purchasers at 3.75% per year maturing March 15, 2030.

“On March 11, 2024, Xerox Holdings Corporation (the “Company”) completed its private offering of $350 million in aggregate principal amount of 3.75% Convertible Senior Notes due 2030 (the “Notes”).”
CXW CoreCivic, Inc.

CoreCivic, Inc. incurred senior notes of $500 million aggregate principal amount with Equiniti Trust Company, LLC, as trustee at 8.250% maturing April 15, 2029.

“On March 12, 2024, CoreCivic, Inc., a Maryland corporation (the “Company”), completed the previously announced public offering (the “Notes Offering”) of $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (the “Notes”), which are fully and unconditionally guaranteed, on a senior unsecured basis, by the Guarantors (as defined below) (the “Guarantees”).”
WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP

WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP incurred senior notes of $500,000,000 aggregate principal amount with Computershare Trust Company, National Association; U.S. Bank Trust Company, National Association at 5.611% per year maturing March 11, 2034.

“On March 11, 2024, Westinghouse Air Brake Technologies Corporation (the “Company”) completed a public offering and sale of $500,000,000 aggregate principal amount of the Company’s 5.611% Senior Notes due 2034 (the “notes”).”
NKE NIKE, Inc.

NIKE, Inc. incurred revolving credit of up to $1.0 billion of borrowings with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders at Term SOFR plus 0.10% plus an applicable margin maturing March 7, 2025.

“On March 8, 2024, NIKE, Inc. (the “Company”) entered into a Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders (the “364‐Day Credit Agreement”). The 364‐Day Credit Agreement provides for up to $1.0 billion of borrowings pursuant to a 364-day unsecured revolving credit facility”
RENX RenX Enterprises Corp.

RenX Enterprises Corp. incurred credit facility of up to the maximum amount of $250,000 with Bryan Leighton Revocable Trust Dated December 13th, 2023 at a fixed rate per annum equal to 12.0% maturing September 1, 2024.

“On March 1, 2024 Safe and Green Development Corporation (the "Company") entered into a credit agreement (the “Credit Agreement”) with the Bryan Leighton Revocable Trust Dated December 13th, 2023 (the “Lender”) pursuant to which the Lender agreed to provide the Company with a line of credit facility (the “Line of Credit”) up to the maximum amount of $250,000”
Nova Vision Acquisition Corp

Nova Vision Acquisition Corp incurred loan of $50,000 with Nova Pulsar Holdings Limited at do not bear interest maturing mature upon the closing of a business combination by the Company.

“(b) an unsecured promissory note in the aggregate principal amount of $50,000 (the "Working Capital Note") in exchange for Sponsor providing such amount to the Company as working capital”
Nova Vision Acquisition Corp

Nova Vision Acquisition Corp incurred loan of $69,763.37 with Nova Pulsar Holdings Limited at do not bear interest maturing mature upon the closing of a business combination by the Company.

“On March 8, 2024, Nova Vision Acquisition Corp. (the "Company") issued to Nova Pulsar Holdings Limited, the Company’s initial public offering sponsor ("Sponsor") (a) an unsecured promissory note in the aggregate principal amount of $69,763.37 (the "Extension Note") in exchange for Sponsor depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination”
OPAL OPAL Fuels Inc.

OPAL Fuels Inc. amended credit facility of $2.0 million each on the last business day of each fiscal quarter in 2024, and to the extent funds are available on such.

“The Credit Agreement Amendment and the Depositary Agreement Amendment together require prepayments of principal in the amount of $2.0 million each on the last business day of each fiscal quarter in 2024, and to the extent funds are available on such dates, additional prepayments in the amounts of $2.5 million, $6.0 million, $10.0 million and $15.0 million (each a “Target Aggregate Special Principal Prepayment Amount”)”
OPAL OPAL Fuels Inc.

OPAL Fuels Inc. amended term loan of from a maximum aggregate principal amount of $85.0 million to approximately $81.0 million.

“Availability under the Credit Agreement’s delayed term loan facility (the “DDTL Facility”) has been reduced from a maximum aggregate principal amount of $85.0 million to approximately $81.0 million”
OPAL OPAL Fuels Inc.

OPAL Fuels Inc. amended revolving credit of up to a maximum aggregate principal amount of $10.0 million with Bank of Montreal at substantially the same terms as the DSR Facility.

“the Credit Agreement Amendment reclassifies the debt service reserve facility (the “DSR Facility”) under the Credit Agreement as a revolving loan facility of up to a maximum aggregate principal amount of $10.0 million (the “Revolving Loan Facility”) on substantially the same terms as the DSR Facility”
Blue Owl Credit Income Corp.

Blue Owl Credit Income Corp. amended credit facility with Deutsche Bank AG, New York Branch.

“In connection with the CLO Transaction, on March 7, 2024, Core Income Funding II LLC, entered into Amendment No. 7 (the “Amendment” and the facility as amended, the “Secured Credit Facility”), which amended that certain Loan Financing and Servicing Agreement, dated as of October 5, 2021 (as amended by Amendment No. 1, dated as of October 27, 2021, Amendment No. 2, dated as of December 20, 2021, Amendment No. 3, dated as of February 18, 2022, Amendment No. 4, dated as of April 11, 2022, Amendment No. 5, dated as of May 3, 2022 and the Joinder Agreement of Webster Bank, N.A, dated as of July 11, 2022, and Amendment No. 6, dated as of August 1, 2022), by and among Core Income Funding II LLC, as borrower, the Company, as equityholder and services provider, the lenders from time to time parties thereto, Deutsche Bank AG, New York Branch, as Facility Agent, State Street Bank and Trust Company, as Collateral Agent and Alter Domus (US) LLC, as Collateral Custodian.”
Blue Owl Credit Income Corp.

Blue Owl Credit Income Corp. incurred senior notes of $597 million term debt securitization with State Street Bank and Trust Company at three-month term SOFR plus 2.00% (Class A), plus 2.50% (Class B), plus 3.30% (Cl maturing April 20, 2036.

“On March 7, 2024 (the “Closing Date”), Blue Owl Credit Income Corp. (the “Company”) completed a $597 million term debt securitization transaction (the “CLO Transaction”), also known as a collateralized loan obligation transaction, which is a form of secured financing incurred by the Company.”
Kiromic Biopharma, Inc.

Kiromic Biopharma, Inc. incurred senior notes of $2,000,000 at 25% per annum maturing March 7, 2025.

“On March 7, 2024, Kiromic BioPharma, Inc. (the “Company”) issued a 25% Senior Secured Convertible Promissory Note (the “Note”) to an accredited investor. The Note has a principal amount of $2,000,000, bears interest at a rate of 25% per annum (the “Stated Rate”) and matures on March 7, 2025”
GSBD Goldman Sachs BDC, Inc.

Goldman Sachs BDC, Inc. incurred senior notes of $400,000,000 with Computershare Trust Company, National Association at 6.375% per year maturing March 11, 2027.

“On March 11, 2024, the Company and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association, the “Trustee”), entered into the Third Supplemental Indenture, dated March 11, 2024, between the Company and the Trustee (the “Third Supplemental Indenture”), which supplements that certain Base Indenture, dated February 10, 2020, between the Company and the Trustee (as may be further amended, supplemented or otherwise modified from time to time, the “Base Indenture” and, together with the Third Supplemental Indenture, the “Indenture”). The Third Supplemental Indenture relates to the Company’s issuance of $ 400,000,000 aggregate principal amount of its 6.375 % notes due 2027 (the “Notes”).”
BIORA THERAPEUTICS, INC.

BIORA THERAPEUTICS, INC. incurred convertible notes of $2,812,500 in aggregate principal amount with Purchaser at 11.00% / 13.00% maturing due 2028.

“the Purchaser agreed to purchase $2,812,500 in aggregate principal amount of additional Notes from the Company for cash at par value”
BIORA THERAPEUTICS, INC.

BIORA THERAPEUTICS, INC. incurred convertible notes of $3,825,000 in aggregate principal amount with Purchaser at 11.00% / 13.00% maturing due 2028.

“the Company agreed to acquire an aggregate of $5,625,000 of the Company’s Existing Notes from the holder in exchange for (i) $3,825,000 in aggregate principal amount of 11.00% / 13.00% Convertible Senior Secured Notes due 2028 (the “Notes”)”
PPCB Propanc Biopharma, Inc.

Propanc Biopharma, Inc. incurred convertible notes of $50,000 with an investor at eight percent (8%) per annum, which may be increased to sixteen percent (16%) in maturing March 1, 2024.

“Effective March 5, 2024, Propanc Biopharma, Inc. (the “Company”) entered into and closed a securities purchase agreement (the “Purchase Agreement”) with an investor (the “Investor”), pursuant to which the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $50,000 (the “Note”), for a purchase price of $46,875.”
TNDM TANDEM DIABETES CARE INC

TANDEM DIABETES CARE INC incurred convertible notes of $316.25 million aggregate principal amount with U.S. Bank Trust Company, National Association at 1.50% per year maturing March 15, 2029.

“On March 8, 2024, Tandem Diabetes Care, Inc. (the “Company”) completed its previously announced private offering (the “Offering”) of $316.25 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $41.25 million principal amount of Notes.”
DYAI DYADIC INTERNATIONAL INC

DYADIC INTERNATIONAL INC incurred convertible notes of $6,000,000 with immediate family members and family trusts related to Mark Emalfarb, including The Francisco Trust U/A/D February 28, 1996 at 8% per annum maturing March 8, 2027.

“On March 8, 2024, Dyadic International, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) pursuant to which the Company issued 8.0% Senior Secured Convertible Promissory Notes due March 8, 2027 in an aggregate principal amount of $6.0 million (the “Convertible Notes”).”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.